CLINICAL_TRIALS trial_result · 2022-04-25

Clinical Trial Update: Safety and Tolerability of WVE-120102 in Patients With Huntington's Disease [Phase 1, Phase 2]

Phase 1/2 trial of WVE-120102 in Huntington's disease was terminated; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Wave Life Sciences Ltd. | Conditions: Huntington's Disease | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2022-04-25